NCT00135824View on ClinicalTrials.gov

Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
Healthy
Interventions
DRUG

Povidone K25 eye drops (povidone)

Trial Locations (1)

69120

Novartis Investigational Site, Heidelberg

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY